Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 1/2013

01-02-2013 | Clinical Investigation

Neointimal Hyperplasia after Silverhawk Atherectomy versus Percutaneous Transluminal Angioplasty (PTA) in Femoropopliteal Stent Reobstructions: A Controlled, Randomized Pilot Trial

Authors: Marianne Brodmann, Peter Rief, Harald Froehlich, Andreas Dorr, Thomas Gary, Philipp Eller, Franz Hafner, Hannes Deutschmann, Gerald Seinost, Ernst Pilger

Published in: CardioVascular and Interventional Radiology | Issue 1/2013

Login to get access

Abstract

Background

Due to intimal hyperplasia instent reobstruction in the femoropopliteal arterial segment is still an unsolved problem. Different techniques have been discussed in case of reintervention to guarantee longlasting patency rate.

Methods

We conducted a randomized, controlled, pilot trial comparing Silverhawk atherectomy with percutaneous transluminal angioplasty (PTA) in patients with a first instent reobstruction in the femoropopliteal arterial segment, to evaluate intima media thickness (IMT) within the treated segment, as a parameter of recurrence of intimal hyperplasia.

Results

In a total 19 patients were included: 9 patients in the atherectomy device and 10 patients in the PTA arm. IMT within the treated segment was statistically significantly elevated in all patients treated with the Silverhawk device versus the patients treated with PTA. The obvious differentiation in elevation of IMT in nonfavor for patients treated with the Silverhawk device started at month 2 (max IMT SH 0.178 mm vs. IMT PTA 0.1 mm, p = 0.001) with a spike at month 5 (max IMT SH 0.206 mm vs. IMT PTA 0.145 mm, p = 0.003) and a decline once again at month 6 (max IMT SH 0.177 mm vs. IMT PTA 0.121 mm, p = 0.02). The values for mean IMT performed the same way.

Conclusions

Although Silverhawk atherectomy provides good results at first sight, in the midterm follow-up of treatment of first instent restenosis it did not perform better than PTA as it showed elevated reoccurrence of intimal media hyperplasia.
Literature
1.
go back to reference Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1–S75PubMedCrossRef Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1–S75PubMedCrossRef
2.
go back to reference Tendera M, Aboyans V, Bartelnik ML, Baumgartner I, Clement D, Collet JP et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. The task force on the diagnosis and treatment of peripheral artery diseases of the European society of cardiology (ESC). Eur Heart J 32(22):2851–2906PubMedCrossRef Tendera M, Aboyans V, Bartelnik ML, Baumgartner I, Clement D, Collet JP et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. The task force on the diagnosis and treatment of peripheral artery diseases of the European society of cardiology (ESC). Eur Heart J 32(22):2851–2906PubMedCrossRef
3.
go back to reference Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cenja M, Lammer J, Minar E (2007) Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115:2745–2749PubMedCrossRef Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cenja M, Lammer J, Minar E (2007) Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115:2745–2749PubMedCrossRef
4.
go back to reference Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cenja M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888PubMedCrossRef Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cenja M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888PubMedCrossRef
5.
go back to reference Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M (2005) Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12:6–12PubMedCrossRef Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M (2005) Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12:6–12PubMedCrossRef
6.
go back to reference Laird JR, Katzen BT, Scheinert D et al (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3:267–276PubMedCrossRef Laird JR, Katzen BT, Scheinert D et al (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3:267–276PubMedCrossRef
7.
go back to reference Wissgott C, Kamusella P, Andresen R (2011) Behandlung von Instent-Reokklusionen der femoropoplitealen Arterien mit einem mechanischem Rotationskatheter. Röfo 183:939–944PubMed Wissgott C, Kamusella P, Andresen R (2011) Behandlung von Instent-Reokklusionen der femoropoplitealen Arterien mit einem mechanischem Rotationskatheter. Röfo 183:939–944PubMed
8.
go back to reference Zeller T, Rastan A, Sixt S et al (2006) Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 48:1573–1578PubMedCrossRef Zeller T, Rastan A, Sixt S et al (2006) Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 48:1573–1578PubMedCrossRef
9.
go back to reference Yeo KK, Mail U, Laird JR (2011) Outcomes following treatment of femoropopliteal in-stent restenosis: a single-center experience. Catheter Cardiovasc Interv 78:604–608PubMedCrossRef Yeo KK, Mail U, Laird JR (2011) Outcomes following treatment of femoropopliteal in-stent restenosis: a single-center experience. Catheter Cardiovasc Interv 78:604–608PubMedCrossRef
10.
go back to reference Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K et al (2012) Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 59:16–23PubMedCrossRef Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K et al (2012) Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 59:16–23PubMedCrossRef
11.
go back to reference Schillinger M, Minar E (2009) Past, present and future of femoropopliteal stenting. J Endovasc Ther 16:1147–1152CrossRef Schillinger M, Minar E (2009) Past, present and future of femoropopliteal stenting. J Endovasc Ther 16:1147–1152CrossRef
12.
go back to reference Zeller T, Macharzina R, Tepe G (2010) The role of DES in peripheral in-stent restenosis. J Cardiovasc Surg 51:561–565 Zeller T, Macharzina R, Tepe G (2010) The role of DES in peripheral in-stent restenosis. J Cardiovasc Surg 51:561–565
13.
go back to reference Dick P, Sabeti S, Mlekusch W et al (2008) Conventional balloon angioplasty versus cutting balloon angioplasty for treatment of femoropopliteal in-stent restenosis: a randomized controlled trial. Radiology 248:297–302PubMedCrossRef Dick P, Sabeti S, Mlekusch W et al (2008) Conventional balloon angioplasty versus cutting balloon angioplasty for treatment of femoropopliteal in-stent restenosis: a randomized controlled trial. Radiology 248:297–302PubMedCrossRef
14.
go back to reference Sillingardi R, Cataldi V, Moratto J et al (2010) Mechanical atherectomy in instent restenosis: preliminary results at the iliac and femoropopliteal arteries with the rotarex System. J Cardiovasc Surg 51:543–550 Sillingardi R, Cataldi V, Moratto J et al (2010) Mechanical atherectomy in instent restenosis: preliminary results at the iliac and femoropopliteal arteries with the rotarex System. J Cardiovasc Surg 51:543–550
15.
go back to reference Scheller B, Speck U, Abramjuk C et al (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7):810–814PubMedCrossRef Scheller B, Speck U, Abramjuk C et al (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7):810–814PubMedCrossRef
16.
17.
go back to reference Laird JR, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR (2012) Excimer laser with adjunctive balloon angioplasty and the heparin-coated self expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve months results from the salvage study. Catheter Cardiovasc Interv (Epub ahead of print) Laird JR, Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, Reddy B, Botti C, Jaff MR (2012) Excimer laser with adjunctive balloon angioplasty and the heparin-coated self expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve months results from the salvage study. Catheter Cardiovasc Interv (Epub ahead of print)
18.
go back to reference Soga Y, Iida O, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M (2012) Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol. Catheter Cardiovasc Interv 79:541–548PubMedCrossRef Soga Y, Iida O, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M (2012) Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol. Catheter Cardiovasc Interv 79:541–548PubMedCrossRef
19.
go back to reference Shrikhande G, McKinsey JF (2008) Use and abuse of atherectomy: where should it be used? Semin Vasc Surg 21:204–209PubMedCrossRef Shrikhande G, McKinsey JF (2008) Use and abuse of atherectomy: where should it be used? Semin Vasc Surg 21:204–209PubMedCrossRef
20.
go back to reference Garcia LA, Lyden SP (2009) Atherectomy for infrainguinal peripheral artery disease. J Endovasc Ther 16(Suppl II):105–115 Garcia LA, Lyden SP (2009) Atherectomy for infrainguinal peripheral artery disease. J Endovasc Ther 16(Suppl II):105–115
21.
go back to reference Speck U, Scheller B, Abramjuk C et al (2006) Neointima inhibition: comparison of effectiveness of nonstent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240:411–418PubMedCrossRef Speck U, Scheller B, Abramjuk C et al (2006) Neointima inhibition: comparison of effectiveness of nonstent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240:411–418PubMedCrossRef
22.
go back to reference Cremers B, Biedermann M, Mahnkopf D et al (2009) Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 98:325–330PubMedCrossRef Cremers B, Biedermann M, Mahnkopf D et al (2009) Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 98:325–330PubMedCrossRef
23.
go back to reference Cremers B, Speck U, Kaufels N et al (2009) Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 101:201–206PubMed Cremers B, Speck U, Kaufels N et al (2009) Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 101:201–206PubMed
25.
go back to reference Margolis J, McDonald J, Heuser R, Klinke P, Waksman R, Virmani R, Desai N, Hilton D (2007) Systemic nanoparticle paclitaxel (nab-Paclitaxel) for in-stent restenosis I (SNAPIST-I): a first in-human safety and dose-finding study. Clin Cardiol 30:165–170PubMedCrossRef Margolis J, McDonald J, Heuser R, Klinke P, Waksman R, Virmani R, Desai N, Hilton D (2007) Systemic nanoparticle paclitaxel (nab-Paclitaxel) for in-stent restenosis I (SNAPIST-I): a first in-human safety and dose-finding study. Clin Cardiol 30:165–170PubMedCrossRef
Metadata
Title
Neointimal Hyperplasia after Silverhawk Atherectomy versus Percutaneous Transluminal Angioplasty (PTA) in Femoropopliteal Stent Reobstructions: A Controlled, Randomized Pilot Trial
Authors
Marianne Brodmann
Peter Rief
Harald Froehlich
Andreas Dorr
Thomas Gary
Philipp Eller
Franz Hafner
Hannes Deutschmann
Gerald Seinost
Ernst Pilger
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 1/2013
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-012-0479-9

Other articles of this Issue 1/2013

CardioVascular and Interventional Radiology 1/2013 Go to the issue